Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
analyst-color
3 min read • August 30, 2018
Cronos Group Plummets After Citron Calls It The ‘Dark Side Of Cannabis’
2 min read • August 29, 2018
Tilray’s First Earnings Print Gives Cannabis Stocks Another Boost
3 min read • August 27, 2018
Cannabis Stocks Remain Hot, But Might Be Getting Overheated
1 min read • August 27, 2018
420 Investor’s Alan Brochstein, On Recent Bull Run In Cannabis Stocks, Tells Benzinga Tilray, Cronos & Canopy Growth Benefit Disproportionately From U.S. Listing Status, Adds Those Cos. ‘Seem expensive to me. Tilray, especially, with its very tight float’
2 min read • July 20, 2018
Pennsylvania Official Calls For Marijuana Taxation
3 min read • June 26, 2018
420 Investor: Cannabis Drug Approval Creates ‘Logic Issue’ For The US Government
5 min read • January 25, 2018
Why GW Pharma’s Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics
1 min read • January 25, 2018
420 Investor Alan Brochstein Notes While He Sold Out Of His Positions In More Speculative Cannabis Names Following Rescinding Of Cole Memo, He ‘kept 5 or 6% exposure to GW Pharma’
1 min read • January 25, 2018
420 Investor Alan Brochstein Responds To Publication Of GW Pharma’s Epidiolex Study Results In Lancet: ‘Results aren’t really news. What’s actually more relevant is the fact that peer-reviewed medical journals are publishing cannabis-related results.’
1 min read • January 5, 2018
Height Securities, On Atty General Sessions Anti-Marijuana Policy, Notes That By Not Giving Prosecutors Any Actual, Add’l Resources, Unlikely For This To Interrupt Positive Momentum Of Marijuana Industry
1 min read • January 3, 2018
ICYMI: Intel’s Issues Impact AMD, Nvidia A Favorite At BofA, Citron Calls Out Cannabis Company
2 min read • August 8, 2017
Is GW Pharma Now The Future Of Cannabis-Based Drugs?
Latest Headlines
View All
2 min read • June 2, 2026
Vireo Growth Reshapes Share Structure After Major Expansion Transactions
2 min read • June 2, 2026
Cannabis Giant, Verano, Joins Industry Peers In Reverse Stock Split Trend With 1-For-5 Consolidation
7 min read • June 2, 2026
Cannabis M&A Is Back, But Not The Way Investors Expected
4 min read • June 2, 2026
EXCLUSIVE: Virginia Governor Defends Cannabis Veto, Citing Timeline And Licensing Concerns
2 min read • June 1, 2026
Five-Month Hemp Enforcement Grace Period Ends In Oregon, Here’s What Businesses Must Know
3 min read • June 1, 2026
New Tennessee Hemp Rules Threaten THCa Market And Millions Of Dollars In Sales
3 min read • June 1, 2026
Robinhood Opens The Door To U.S. Cannabis Stocks
4 min read • June 1, 2026
Fireman Entrepreneur Award Builds Momentum Ahead of 2026 Announcement in Chicago
4 min read • June 1, 2026
Thin Legal Challenge from State AGs Could Still Complicate Federal Cannabis Rescheduling Effort
2 min read • May 29, 2026
Canopy Growth Bets On Europe As It Relaunches This Legacy Brand in Germany’s $1B Medical Cannabis Market
2 min read • May 29, 2026
Minnesota’s New Cannabis Bill Reshapes Market For Medical And Rec Operators
2 min read • May 28, 2026
New Study Tracks How Cannabis Beverages Are Replacing Alcohol In Everyday Settings
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis earnings
cannabis farms
cannabis study
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
Hot
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.